These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 15561809)
1. The past decade of experience with isolated hepatic perfusion. Grover A; Alexander HR Oncologist; 2004; 9(6):653-64. PubMed ID: 15561809 [TBL] [Abstract][Full Text] [Related]
2. Current status of isolated hepatic perfusion with or without tumor necrosis factor for the treatment of unresectable cancers confined to liver. Alexander HR; Bartlett DL; Libutti SK Oncologist; 2000; 5(5):416-24. PubMed ID: 11040278 [TBL] [Abstract][Full Text] [Related]
3. Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver. Alexander HR; Libutti SK; Pingpank JF; Steinberg SM; Bartlett DL; Helsabeck C; Beresneva T Clin Cancer Res; 2003 Dec; 9(17):6343-9. PubMed ID: 14695133 [TBL] [Abstract][Full Text] [Related]
4. A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver. Alexander HR; Libutti SK; Bartlett DL; Puhlmann M; Fraker DL; Bachenheimer LC Clin Cancer Res; 2000 Aug; 6(8):3062-70. PubMed ID: 10955785 [TBL] [Abstract][Full Text] [Related]
5. Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy. Alexander HR; Libutti SK; Bartlett DL; Pingpank JF; Kranda K; Helsabeck C; Beresnev T Cancer; 2002 Aug; 95(4):730-6. PubMed ID: 12209715 [TBL] [Abstract][Full Text] [Related]
6. Isolated hepatic perfusion with high-dose melphalan results in immediate alterations in tumor gene expression in patients with metastatic ocular melanoma. Varghese S; Xu H; Bartlett D; Hughes M; Pingpank JF; Beresnev T; Alexander HR Ann Surg Oncol; 2010 Jul; 17(7):1870-7. PubMed ID: 20221901 [TBL] [Abstract][Full Text] [Related]
7. Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan. Lindnér P; Fjälling M; Hafström L; Kierulff-Nielsen H; Mattsson J; Scherstén T; Rizell M; Naredi P Eur J Surg Oncol; 1999 Apr; 25(2):179-85. PubMed ID: 10218462 [TBL] [Abstract][Full Text] [Related]
8. Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases. van Etten B; de Wilt JH; Brunstein F; Eggermont AM; Verhoef C Eur J Surg Oncol; 2009 May; 35(5):539-45. PubMed ID: 18760560 [TBL] [Abstract][Full Text] [Related]
9. Isolated limb perfusion with tumour necrosis factor-alpha and melphalan for unresectable bone sarcomas of the lower extremity. Bickels J; Manusama ER; Gutman M; Eggermont AM; Kollender Y; Abu-Abid S; Van Geel AN; Lev-Shlush D; Klausner JM; Meller I Eur J Surg Oncol; 1999 Oct; 25(5):509-14. PubMed ID: 10527599 [TBL] [Abstract][Full Text] [Related]
10. Isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: recent trends and perspectives. Rothbarth J; Tollenaar RA; Schellens JH; Nortier JW; Kool LJ; Kuppen PJ; Mulder GJ; van de Velde CJ Eur J Cancer; 2004 Aug; 40(12):1812-24. PubMed ID: 15288282 [TBL] [Abstract][Full Text] [Related]
12. Augmented capillary leak during isolated hepatic perfusion (IHP) occurs via tumor necrosis factor-independent mechanisms. Alexander HR; Brown CK; Bartlett DL; Libutti SK; Figg WD; Raje S; Turner E Clin Cancer Res; 1998 Oct; 4(10):2357-62. PubMed ID: 9796965 [TBL] [Abstract][Full Text] [Related]
13. Isolated hepatic perfusion for liver metastases of malignant melanoma. Rizell M; Mattson J; Cahlin C; Hafström L; Lindner P; Olausson M Melanoma Res; 2008 Apr; 18(2):120-6. PubMed ID: 18337648 [TBL] [Abstract][Full Text] [Related]
14. A new method of antitumor therapy with a high dose of TNF perfusion for unresectable liver tumors. Nakamoto T; Inagawa H; Takagi K; Soma G Anticancer Res; 2000; 20(6A):4087-96. PubMed ID: 11131677 [TBL] [Abstract][Full Text] [Related]
15. Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020. Cornett WR; McCall LM; Petersen RP; Ross MI; Briele HA; Noyes RD; Sussman JJ; Kraybill WG; Kane JM; Alexander HR; Lee JE; Mansfield PF; Pingpank JF; Winchester DJ; White RL; Chadaram V; Herndon JE; Fraker DL; Tyler DS; J Clin Oncol; 2006 Sep; 24(25):4196-201. PubMed ID: 16943537 [TBL] [Abstract][Full Text] [Related]
16. Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver. Vahrmeijer AL; van Dierendonck JH; Keizer HJ; Beijnen JH; Tollenaar RA; Pijl ME; Marinelli A; Kuppen PJ; van Bockel JH; Mulder GJ; van de Velde CJ Br J Cancer; 2000 May; 82(9):1539-46. PubMed ID: 10789721 [TBL] [Abstract][Full Text] [Related]
17. A phase I study of hyperthermic isolated hepatic perfusion with oxaliplatin in the treatment of unresectable liver metastases from colorectal cancer. Zeh HJ; Brown CK; Holtzman MP; Egorin MJ; Holleran JL; Potter DM; Bartlett DL Ann Surg Oncol; 2009 Feb; 16(2):385-94. PubMed ID: 19034580 [TBL] [Abstract][Full Text] [Related]
18. Isolated hepatic perfusion for the treatment of patients with advanced liver metastases from pancreatic and gastrointestinal neuroendocrine neoplasms. Grover AC; Libutti SK; Pingpank JF; Helsabeck C; Beresnev T; Alexander HR Surgery; 2004 Dec; 136(6):1176-82. PubMed ID: 15657573 [TBL] [Abstract][Full Text] [Related]
19. Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma. Hayes AJ; Neuhaus SJ; Clark MA; Thomas JM Ann Surg Oncol; 2007 Jan; 14(1):230-8. PubMed ID: 17066234 [TBL] [Abstract][Full Text] [Related]
20. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy. Thijssens KM; van Ginkel RJ; Pras E; Suurmeijer AJ; Hoekstra HJ Ann Surg Oncol; 2006 Apr; 13(4):518-24. PubMed ID: 16485147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]